LONDONReckitt Benckiser Group PLC said Monday that it would seek to list its pharmaceutical operation on the London Stock Exchange within the next  months ending months of speculation RB Pharmaceuticals valued by analysts at  billion to  billion posted a  drop in secondquarter revenue For the second quarter last year RB Pharmaceuticals revenue declined  The capitalmarkets solution hasnt come as a surprise because Reckitt flagged the potential disposal of the ailing drug unit in October